Position in TBPH
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$437,040
+$363,286 QoQ
Shares Held
26,928
+583.1% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $2,996,125,878 across 242 Biotechnology names. TBPH ranks #129 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,955,764 | $873,326,855 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
732,054 | $565,614,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
934,881 | $309,324,075 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,362,872 | $161,316,968 | |
| 5 | INCY |
Incyte Corp
|
1,543,188 | $145,244,853 | |
| 6 | INSM |
INSMED Inc
|
787,079 | $128,703,157 | |
| 7 | ARGX |
Argenx SE
|
150,850 | $110,158,211 | |
| 8 | MRNA |
Moderna, Inc.
|
750,841 | $38,142,721 |
All Filings in TBPH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $437,040 | 26,928 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $73,754 | 3,942 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $56,399 | 3,863 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $45,664 | 4,140 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $29,754 | 3,332 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $387,860 | 41,218 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $435,842 | 54,075 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $458,555 | 54,075 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $470,197 | 52,419 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $566,427 | 50,394 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $477,937 | 55,381 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $591,978 | 57,196 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $616,224 | 56,795 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $621,486 | 55,391 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $566,409 | 55,859 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $533,670 | 58,904 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $548,629 | 57,388 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $634,235 | 57,397 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $316,341 | 42,749 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $457,742 | 31,525 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $634,015 | 31,064 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $555,578 | 31,265 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $462,252 | 31,265 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $703,059 | 33,495 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $785,462 | 33,988 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||